TG Therapeutics Director Laurence N. Charney Gifts 6,050 Shares

What Happened Laurence N. Charney, a director of TG Therapeutics (TGTX), disposed of a total of 6,050 shares as gifts to charity: 5,100 shares on 2026-08-06 and 500 and 450 shares on 2026-08-07. All transactions are reported as gifts (transaction code G) with a reported price of $0.00, so no proceeds were received. Footnote in the filing states these were bona fide gifts to a 501(c)(3) and that the reporting person does not retain any beneficial ownership or pecuniary interest in the gifted shares.

Key Details

• Transaction dates and amounts: 2026-08-06 — 5,100 shares (gift); 2026-08-07 — 500 shares (gift) and 450 shares (gift). Reported price per share: $0.00.
• Total shares gifted: 6,050; total proceeds reported: $0.
• Shares owned after transaction: filing does not state a post-transaction total; footnote clarifies no beneficial ownership retained for the gifted shares.
• Notable footnotes: F1 — gifts to a 501(c)(3), no retained interest; F2 — filing notes some reported holdings include restricted common stock that vests over time.
• Filing timeliness: period of report 2026-08-06, filed 2026-08-07; no late filing flag indicated.

Context Gifts are disposals for reporting purposes and do not necessarily reflect the insider’s view of the company’s prospects; they are commonly used for charitable donations or estate planning. Because these transfers were charitable gifts with no proceeds and the filer retains no beneficial interest, they should not be read as a conventional sale signaling sentiment about the stock.